Clinical Trial Update: Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo [Phase 4]

View source ↗

Summary

Phase 4 randomized trial assessing neuropsychiatric symptoms (depression, anxiety, irritability, and suicidal thoughts or behavior) in adults quitting smoking w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Varenicline tartrate (varenicline tartrate)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED | Results posted: 2010-08-09